Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
about
Genetic polymorphisms of Bcl-2 promoter in cancer susceptibility and prognosis: a meta-analysis.Single Nucleotide Polymorphisms in Selected Apoptotic Genes and BPDE-Induced Apoptotic Capacity in Apparently Normal Primary Lymphocytes: A Genotype-Phenotype Correlation AnalysisBCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility.The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.Functional BCL-2 regulatory genetic variants contribute to susceptibility of esophageal squamous cell carcinoma.The BCL2 -938C>A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty.BCL2-938C>A and CALCA-1786T>C polymorphisms in aseptic loosened total hip arthroplastyPolymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients.Study of the regulatory promoter polymorphism (-938C>A) of B-cell lymphoma 2 gene in breast cancer patients of Mazandaran province in Northern Iran.Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.
P2860
Q33648842-F8E5F2A1-4594-4F65-B87A-262B763176B2Q33807908-595E2D21-B512-41FC-9FBF-2F4965B00687Q33860466-A5A3EC64-B49A-4C82-A22E-FA71FE089958Q35006917-FE9E967D-6F23-46A0-98A9-D98CB933E117Q35804218-EBBEBFD2-EDBF-4181-97A3-4327D3A376BAQ35924952-43AD277E-0DCB-43BB-A199-214485129724Q35959284-58B03EA9-14F7-4052-B29C-C6B5AB08BA67Q36360770-D2A93456-9FCE-43D5-86DE-2C587F472F13Q37052173-4D517A89-ED70-496F-A132-8444156969B6Q37735285-81E509B1-7FA2-4DB5-821D-39CF2329C853Q37741375-C109A554-CF5B-4613-8749-AFDE9616132CQ39612017-C7037D88-CB6A-4128-B0DF-64A926DA10D2
P2860
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
@en
type
label
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
@en
prefLabel
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).
@en
P2093
P1476
Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2)
@en
P2093
Byung Lae Park
Eun Mi Kim
Hye Young Cho
Hyoung Doo Shin
Hyun Sub Cheong
Lyoung Hyo Kim
Yong-Sun Kim
P2888
P304
P356
10.1007/S10038-004-0173-0
P577
2004-07-22T00:00:00Z